Dietary flavonoids: effects on xenobiotic and carcinogen metabolism

YJ Moon, X Wang, ME Morris - Toxicology in vitro, 2006 - Elsevier
Flavonoids are present in fruits, vegetables and beverages derived from plants (tea, red
wine), and in many dietary supplements or herbal remedies including Ginkgo Biloba, Soy …

Modulation of endogenous antioxidant system by wine polyphenols in human disease

R Rodrigo, A Miranda, L Vergara - Clinica Chimica Acta, 2011 - Elsevier
Numerous studies indicate that moderate red wine consumption is associated with a
protective effect against all-cause mortality. Since oxidative stress constitutes a unifying …

Natural polyphenols against neurodegenerative disorders: potentials and pitfalls

A Ebrahimi, H Schluesener - Ageing research reviews, 2012 - Elsevier
Within the last years, a rapidly growing number of polyphenolic compounds with
neuroprotective effects have been described. Many efforts have been made to explore the …

[HTML][HTML] Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31–June 1, 2005, Washington, DC1

JW Erdman Jr, D Balentine, L Arab, G Beecher… - The Journal of …, 2007 - Elsevier
This article provides an overview of current research on flavonoids as presented during a
workshop entitled,“Flavonoids and Heart Health,” held by the ILSI North America Project …

Drug interactions in cancer therapy

CD Scripture, WD Figg - Nature Reviews Cancer, 2006 - nature.com
Drug interactions in oncology are of particular importance owing to the narrow therapeutic
index and the inherent toxicity of anticancer agents. Interactions with other medications can …

[HTML][HTML] Risks and safety of polyphenol consumption

LI Mennen, R Walker, C Bennetau-Pelissero… - The American journal of …, 2005 - Elsevier
This article gives an overview of the potential hazards of polyphenol consumption, as
reported during the round-table discussion at the 1st International Conference on …

Herbal modulation of P‐glycoprotein

S Zhou, LY Lim, B Chowbay - Drug metabolism reviews, 2004 - Taylor & Francis
P‐glycoprotein (Pgp) is a 170 kDa phosphorylated glycoprotein encoded by human MDR1
gene. It is responsible for the systemic disposition of numerous structurally and …

Prediction of intestinal first-pass drug metabolism

J Yang, M Jamei, KR Yeo, GT Tucker… - Current drug …, 2007 - ingentaconnect.com
Despite a lower content of many drug metabolising enzymes in the intestinal epithelium
compared to the liver (eg intestinal CYP3A abundance in the intestine is 1% that of the liver) …

Discovery and characterization of potent dual P-glycoprotein and CYP3A4 inhibitors: design, synthesis, cryo-EM analysis, and biological evaluations

S Urgaonkar, K Nosol, AM Said… - Journal of Medicinal …, 2021 - ACS Publications
Targeted concurrent inhibition of intestinal drug efflux transporter P-glycoprotein (P-gp) and
drug metabolizing enzyme cytochrome P450 3A4 (CYP3A4) is a promising approach to …

The effect of grapefruit juice on drug disposition

MJ Hanley, P Cancalon, WW Widmer… - Expert opinion on drug …, 2011 - Taylor & Francis
Introduction: Since their initial discovery in 1989, grapefruit juice (GFJ)–drug interactions
have received extensive interest from the scientific, medical, regulatory and lay communities …